Oxford Global Conferences is proud to present both the 11^th Annual Drug Discovery Leaders Summit, which is to be held on the 9^th- 10^th and its Pre-Conference Symposium on Open Innovation on the 8^th June 2010 at Le Montreux Palace, Switzerland. The summit is the single most senior-level and focused event in Europe dedicated to the drug discovery and pharma market.  Over three days, the Summit will attract over 200 senior-level decision makers working in drug discovery from the UK, Europe and US’s leading pharmaceutical, biotech, academic and research institutions.  This prestigious event provides a forum for R&D and drug discovery practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment. This meeting will also be co-located with Oxford Global’s 2^nd Annual GPCR Congress.

Event Information: Oxford Global Conferences is proud to present the GPCR Congress 2010  which is to be held on the 9^th & 10^th June in Montreux, Switzerland. The congress is the single most focused event in Europe dedicated to key technological and scientific trends in GPCR’s in the pharmaceutical and biotech industry, as well as academic institutions.  It will also be co-located with our 11th Annual Drug Discovery Leaders Summit.

Event Information : The summit is the single most senior-level and focused event in Asia Pacific dedicated to the Drug Discovery & Development of Vaccines, Biologics, Biogenerics and Anitbodies, R&D Strategies, Alliances and Partnership, as well as Bioinformatics and Data Management.

Event information: Oxford Global Conferences is proud to present the 3^rd Annual Proteins Congress 2010 which is to be held on the 28^th & 29^th October at the Kempinski Bristol Berlin Hotel. The congress is the single most focused event in Europe dedicated to key technological and scientific trends in Proteins in the pharmaceutical and biotech industry, as well as academic institutions.  It will also be co-located with our Vaccines Congress.

With the ever-expanding protein therapeutic market, there is a need for the bio/pharma industry to reassess the technology, discovery and delivery trends.  Protein expression & characterisation systems are rapidly evolving, and there is more pressure to harvest larger, purer quantities of product to support research pipelines. More efficient methods are also needed to identify and analyse proteins involved in disease populations with the aim to discover novel diagnostic tools and treatments. The conference also looks at effective strategies in protein assays and microarrays and data mining in discovery. Over two days, the 2 events will attract over 150 senior-level decision makers working in Proteins development from the UK, Europe and US.

Oxford Global Conferences is proud to present the 2^nd Annual qPCR Congress 2010 (www.qpcr-congress.com), which is to be held on the 15^th & 16^th November 2010 in London. The congress is the single most focused event in Europe dedicated to key technological and scientific trends & advances in qPCR in the pharmaceutical and biotech industry, as well as academic institutions. This conference explores effective strategies, technologies and applications of qPCR in accelerating drug discovery and the development of clinical diagnostics. Over two days, the event will attract over 120 senior-level decision makers working in discovery, biomarkers, gene expression, molecular biology, and clinical & diagnostics development and bioinformatics & data management from the UK, Europe and US. 

Event Information: Oxford Global Conferences is proud to present Next Generation Sequencing (NGS)Congress, which is to be held on the 15^th & 16^th November 2010  in London. The congress is held in conjunction with qPCR Congress( www.qpcr-congress.com).

Over the 2 days, the conference provides an overview of the current options of next-generation sequencing platforms, technologies, applications and the newest computational tools for the analysis of next-generation sequencing data.  

The event will attract over 120 senior-level decision makers working in bioinformatics & data management, next generation sequencing, discovery, RNA profiling, molecular genomics, and clinical & diagnostics development from the UK, Europe and US.  This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.